MX355780B - Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal. - Google Patents

Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal.

Info

Publication number
MX355780B
MX355780B MX2013007680A MX2013007680A MX355780B MX 355780 B MX355780 B MX 355780B MX 2013007680 A MX2013007680 A MX 2013007680A MX 2013007680 A MX2013007680 A MX 2013007680A MX 355780 B MX355780 B MX 355780B
Authority
MX
Mexico
Prior art keywords
human milk
milk oligosaccharides
beneficial bacteria
promote growth
neutral human
Prior art date
Application number
MX2013007680A
Other languages
English (en)
Other versions
MX2013007680A (es
Inventor
Chow Jomay
R Davis Steven
Buck Rachael
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MX2013007680A publication Critical patent/MX2013007680A/es
Publication of MX355780B publication Critical patent/MX355780B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pediatric Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a una fórmula pediátrica sintética para usarse en estimular las células nervosas entéricas en el tracto gastrointestinal de un individuo, la fórmula pediátrica sintética comprende un oligosacárido neutro de leche humana seleccionado del grupo que consiste en 2´-fucolillactosa o 3´-fucosillactosa.
MX2013007680A 2010-12-31 2011-12-22 Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal. MX355780B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201061428867P 2010-12-31 2010-12-31
US201161474691P 2011-04-12 2011-04-12
PCT/US2011/067031 WO2012092160A2 (en) 2010-12-31 2011-12-22 Human milk oligosaccharides to promote growth of beneficial bacteria

Publications (2)

Publication Number Publication Date
MX2013007680A MX2013007680A (es) 2013-09-26
MX355780B true MX355780B (es) 2018-04-30

Family

ID=45496315

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2013007680A MX355780B (es) 2010-12-31 2011-12-22 Fórmula pediátrica sintética para estimular células nerviosas entéricas en el tracto gastrointestinal.
MX2018005297A MX2018005297A (es) 2010-12-31 2013-06-28 Formula pediatrica sintetica para estimular celulas nerviosas entericas en el tracto gastrointestinal.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2018005297A MX2018005297A (es) 2010-12-31 2013-06-28 Formula pediatrica sintetica para estimular celulas nerviosas entericas en el tracto gastrointestinal.

Country Status (13)

Country Link
US (4) US11337990B2 (es)
EP (2) EP2658401A2 (es)
CN (2) CN103402376A (es)
BR (1) BR112013016929A2 (es)
CA (2) CA3167205A1 (es)
HK (1) HK1255687A1 (es)
MX (2) MX355780B (es)
MY (2) MY174542A (es)
NZ (1) NZ612455A (es)
PH (1) PH12013501381A1 (es)
SG (2) SG191393A1 (es)
TW (1) TW201233334A (es)
WO (1) WO2012092160A2 (es)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2658549B1 (en) 2010-12-31 2020-06-03 Abbott Laboratories Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
CN103402376A (zh) 2010-12-31 2013-11-20 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
CN107019701B (zh) 2010-12-31 2020-07-28 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
CN113662199A (zh) * 2011-08-29 2021-11-19 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
DK2708147T3 (da) * 2012-09-14 2020-05-18 Abbott Lab Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose
ES2572831T3 (es) * 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
CN107853705A (zh) * 2012-11-02 2018-03-30 N·V·努特里奇亚 用于改善大脑的合生素组合物
TW201438719A (zh) 2012-12-18 2014-10-16 Abbott Lab 改善壓力症狀之母乳寡糖
WO2014100022A1 (en) * 2012-12-18 2014-06-26 Abbott Laboratories Dietary oligosaccharides to enhance learning and memory
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
EP2996487B1 (en) 2013-03-08 2019-12-11 Axiom Foods Inc. Rice protein supplements
CN105246342A (zh) 2013-03-13 2016-01-13 普罗莱克塔生物科学公司 高脂人乳产品
CA3176938A1 (en) * 2013-08-09 2015-02-12 Ab-Biotics, S.A. Probiotic for infantile excessive crying
US10568896B2 (en) 2013-11-19 2020-02-25 Abbott Laboratories Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
US10695358B2 (en) 2013-12-20 2020-06-30 Abbott Laboratories Oral rehydration composition with oligosaccharides
EP2888950A1 (en) * 2013-12-24 2015-07-01 Abbott Laboratories Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment
ES2701163T3 (es) * 2014-01-20 2019-02-21 Jennewein Biotechnologie Gmbh Procedimiento para la purificación eficiente de oligosacáridos de la leche humana (HMO) neutros a partir de la fermentación microbiana
CN113331426A (zh) * 2014-04-08 2021-09-03 雅培公司 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法
US20170202864A1 (en) * 2014-07-21 2017-07-20 Abbott Laboratories Nutrient delivery system with human milk oligosaccharides
US10314852B2 (en) 2014-10-24 2019-06-11 Glycom A/S Mixtures of HMOs
US11040049B2 (en) * 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US20200138838A1 (en) * 2014-10-29 2020-05-07 Glycom A/S Composition comprising hmss/hmos and use thereof
PL3212198T3 (pl) * 2014-10-29 2021-08-23 Glycom A/S Syntetyczna kompozycja i sposób promowania gojenia się błony śluzowej
US20160243139A1 (en) * 2014-10-29 2016-08-25 Glycom A/S Composition comprising HMSs/HMOs and use thereof
JP7182872B2 (ja) * 2014-10-29 2022-12-05 グリコム・アクティーゼルスカブ 過敏性腸症候群の治療のための合成組成物および方法
US11040050B2 (en) 2014-10-29 2021-06-22 Glycom A/S Composition comprising HMSs/HMOs and use thereof
US11173170B2 (en) * 2014-11-05 2021-11-16 Optibiotix Limited Prebiotic composition and its methods of production
US10881674B2 (en) 2014-12-08 2021-01-05 Glycom A/S Synthetic composition for treating metabolic disorders
US10987368B2 (en) 2014-12-08 2021-04-27 Glycom A/S Synthetic composition for preventing or treating CVD
WO2016091265A1 (en) * 2014-12-08 2016-06-16 Glycom A/S Synthetic composition for treating metabolic disorders
US10835544B2 (en) 2014-12-08 2020-11-17 Glycom A/S Synthetic composition for regulating satiety
AU2016227597B2 (en) * 2015-03-05 2020-01-16 Société des Produits Nestlé S.A. Compositions for use in improving stool consistency or frequency in infants or young children
ES2947458T3 (es) 2015-03-05 2023-08-09 Nestle Sa Composiciones para su uso en la prevención o el tratamiento de infecciones gastrointestinales en lactantes o niños pequeños
AU2016249380B2 (en) * 2015-04-15 2020-11-12 Prolacta Bioscience, Inc. Human milk compositions and methods of making and using same
PL3368046T3 (pl) 2015-10-28 2022-11-28 Glycom A/S Syntetyczna kompozycja i sposób modulowania funkcji mózgu i zachowania
EP3377071B1 (en) 2015-11-17 2024-01-10 Glycom A/S Human milk oligosaccharides for treating antibiotic associated complications
US11344041B2 (en) 2015-12-30 2022-05-31 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care
RU2735250C2 (ru) * 2016-01-26 2020-10-29 Сосьете Де Продюи Нестле С.А. КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ 2FL И LNnT, ДЛЯ КОНТРОЛЯ ПОТРЕБЛЕНИЯ ПИЩИ И РОСТА У МЛАДЕНЦЕВ ИЛИ ДЕТЕЙ МЛАДШЕГО ВОЗРАСТА
US11229659B2 (en) 2016-01-26 2022-01-25 Societe Des Produits Nestle S.A. Compositions with specific oligosaccharides to prevent or treat allergies
AU2017101895A4 (en) * 2016-01-26 2021-01-28 Société des Produits Nestlé S.A. Compositions with specific oligosaccharides to prevent later in life obesity or related comorbidities, by increasing colonic SCFA production and/or by increasing GLP-1 secretion
CN108471793A (zh) * 2016-01-26 2018-08-31 雀巢产品技术援助有限公司 用于婴儿或幼儿以预防或治疗变态反应的包含人乳低聚糖的组合物
US11096410B2 (en) 2016-01-26 2021-08-24 Societe Des Produits Nestle S.A. Composition for use in the prevention and/or treatment of skin conditions and skin diseases
WO2017144062A1 (en) * 2016-02-24 2017-08-31 Glycom A/S Synthetic composition for microbiota modulation
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
HUE062788T2 (hu) * 2016-04-15 2023-12-28 Baylor College Medicine Lactobacillus reuteri MM4-1A alkalmazása az autizmus spektrumzavar kezelésében vagy megelõzésében
ES2924137T3 (es) 2016-05-05 2022-10-04 Glycom As Composición que comprende HMOS para uso en el tratamiento de la hipersensibilidad y/o dolor visceral mediados por mastocitos
PL3452050T3 (pl) * 2016-05-05 2023-06-12 Glycom A/S Kompozycja zawierająca hmo do leczenia biegunki niezakaźnej
WO2017209156A1 (ja) * 2016-05-31 2017-12-07 森永乳業株式会社 脳機能改善剤
SG11201811227QA (en) 2016-07-01 2019-01-30 Evolve Biosystems Inc Method for facilitating maturation of the mammalian immune system
AU2017298212B2 (en) * 2016-07-18 2020-06-11 Metagenics LLC Compositions and methods for managing digestive disorders and a healthy microbiome
CA3030809A1 (en) 2016-07-28 2018-02-01 Fonterra Co-Operative Group Limited Sialyloligosaccharide product and process
EP3500916B1 (en) 2016-08-17 2024-03-06 Services Pétroliers Schlumberger Graphical representation management
JP6762027B2 (ja) * 2016-08-25 2020-09-30 株式会社雅嘉貿易 シアロオリゴ糖の製造方法とその利用
WO2018046311A1 (en) * 2016-09-07 2018-03-15 Nestec S.A. Nutritional compositions for infants and/or young children comprising oligosaccharides
US20180103675A1 (en) * 2016-10-14 2018-04-19 Mead Johnson Nutrition Company Personalized pediatric nutrition products comprising human milk oligosaccharides
US11019838B2 (en) * 2017-02-21 2021-06-01 Jarrow Formulas, Inc. Probiotic dietary supplement formulation
US11278558B2 (en) 2017-03-01 2022-03-22 Glycom A/S Synthetic composition for microbiota modulation
AU2018265066B2 (en) * 2017-05-09 2023-10-19 Societe Des Produits Nestle S.A. Synergistic production of butyrate associated with the complexity of HMOs blend for use in infants or young children for health purposes
US11291677B2 (en) * 2017-05-09 2022-04-05 Glycom A/S Synthetic composition for microbiota modulation
WO2018209131A1 (en) 2017-05-12 2018-11-15 Axiom Foods, Inc. Rice products and systems and methods for making thereof
US20180333426A1 (en) * 2017-05-17 2018-11-22 Mead Johnson Nutrition Company Nutritional composition with human milk oligosaccharides and uses thereof
EP3630124A4 (en) 2017-05-24 2021-02-24 Glycom A/S SYNTHETIC COMPOSITION CONSISTING OF OLIGOSACCHARIDES AND ITS USE IN MEDICAL TREATMENT
AU2018274636B2 (en) 2017-05-24 2024-05-02 Societe Des Produits Nestle S.A. Composition comprising Human Milk Oligosaccharides (HMO) for use in the improvement of short term memory and other cognitive benefits
WO2018237149A1 (en) 2017-06-21 2018-12-27 Abbott Laboratories METHODS FOR INCREASING THE GROWTH OF BENEFICIAL BACTERIA IN THE GASTROINTESTINAL TRACT
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
EP3450443A1 (en) 2017-08-29 2019-03-06 Jennewein Biotechnologie GmbH Process for purifying sialylated oligosaccharides
SG11202002325VA (en) * 2017-09-13 2020-04-29 Evolve Biosystems Inc Metabolomic revision of mammalian infants
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
JP7327724B2 (ja) * 2017-11-30 2023-08-16 グリコム・アクティーゼルスカブ 小麦過敏症を処置するためのｈｍｏの混合物
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
CN111683666A (zh) * 2017-12-22 2020-09-18 格礼卡姆股份公司 预防或减少伤害感受的包含hmo的组合物
EP3546060A1 (en) * 2018-03-27 2019-10-02 DuPont Nutrition Biosciences ApS Process for spray drying fucosyllactose solutions and related product compositions
WO2019189200A1 (ja) * 2018-03-29 2019-10-03 森永乳業株式会社 栄養組成物並びに該栄養組成物を用いた飲食品組成物及び調製粉乳
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
BR112020022892A2 (pt) 2018-05-31 2021-02-23 Glycom A/S mistura de hmos para tratamento de doenças autoi-munes
CN112423603A (zh) 2018-07-12 2021-02-26 N·V·努特里奇亚 用于改善肠屏障完整性的营养组合物、组合物的制备以及治疗方法
CN110839702A (zh) * 2018-08-21 2020-02-28 内蒙古伊利实业集团股份有限公司 一种改善婴幼儿肠道菌群丰度和粪便气味的母乳低聚糖组合物及其应用
WO2020128948A1 (en) * 2018-12-21 2020-06-25 Glycom A/S Composition and method for promoting intestinal barrier healing
WO2020126587A1 (en) * 2018-12-21 2020-06-25 Societe Des Produits Nestle S.A. A NUTRITIONAL COMPOSITION COMPRISING METABOLITES OF HMOs TO IMPROVE THE GASTROINTESTINAL BARRIER
US20200360418A1 (en) * 2019-05-15 2020-11-19 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
EP3975729A1 (en) * 2019-05-27 2022-04-06 FrieslandCampina Nederland B.V. Nutritional composition
LT3883393T (lt) 2019-06-04 2022-12-27 N.V. Nutricia Mitybinė kompozicija, apimanti 2‘-fukozil-laktozę ir maistinį butiratą
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12005083B1 (en) 2019-06-24 2024-06-11 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US11849747B1 (en) 2019-06-24 2023-12-26 PBM Nutritionals, LLC Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof
US20220273016A1 (en) * 2019-07-18 2022-09-01 The Regents Of The University Of California Human milk oligosaccharides for control of dietary response and metabolic phenotype
WO2021015977A1 (en) * 2019-07-23 2021-01-28 Dupont Nutrition Biosciences Aps Oral healthcare treatment and related compositions
ES1240969Y (es) * 2019-09-18 2020-07-30 Jennewein Biotechnologie Gmbh Composiciones de cereales que contienen oligosacaridos de la leche humana
TW202126317A (zh) * 2019-09-24 2021-07-16 美商普拉塔生技公司 用於治療發炎和免疫疾病之組成物和方法
CN112869170B (zh) * 2019-11-29 2023-05-23 伊利伊诺科技(上海)有限责任公司 可提高胃肠道免疫能力的益生菌益生元营养组合物及应用
CN112869167A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 副干酪乳杆菌k56提升肠道细菌感染抗性和肠道免疫力的应用
CN112515170B (zh) * 2019-11-29 2023-02-21 伊利伊诺科技(上海)有限责任公司 提高胃肠道免疫能力的乳双歧杆菌与益生元组合物及应用
EP4065128A4 (en) * 2019-11-29 2023-12-20 Glycom A/S HMOS BLEND TO IMPROVE THE MICROBIOTA OF PREGNANT WOMEN
CN112870232A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 乳双歧杆菌bl-99提升肠道细菌感染抗性和肠道免疫力的应用
EP4076474A4 (en) * 2019-12-06 2024-02-28 Glycom A/S COMPOSITION CONTAINING 2'-FL AND DFL FOR USE IN A PAIN RELIEF METHOD
CN111011864A (zh) * 2019-12-27 2020-04-17 内蒙古蒙牛乳业（集团）股份有限公司 一种促进肠道健康的营养组分
JP7474596B2 (ja) * 2020-01-20 2024-04-25 森永乳業株式会社 新規ビフィドバクテリウム属細菌、および当該細菌を含む組成物、並びに当該細菌の増殖促進用の組成物
CN112075637B (zh) * 2020-04-27 2023-05-23 合生元（广州）健康产品有限公司 一种减少肠道气体产生的组合物
CN113712207B (zh) * 2020-05-21 2023-06-06 内蒙古伊利实业集团股份有限公司 提高胃肠道免疫能力的益生菌益生元组合物及其应用
CA3188645A1 (en) * 2020-08-14 2022-02-17 Prolacta Bioscience, Inc. Human milk oligosaccharide compositions for use with bacteriotherapies
WO2022046501A1 (en) * 2020-08-24 2022-03-03 Intrinsic Medicine, Inc. Immunomodulatory oligosaccharides for the treatment of autism spectrum disorder
US11541085B2 (en) * 2020-09-29 2023-01-03 Chambio Co., Ltd. Postbiotic extract and preparation process and use thereof
US11517596B2 (en) * 2020-09-29 2022-12-06 Chambioco., Ltd. Method for alleviating arthritis with postbiotic extract
CN116322372A (zh) 2020-10-13 2023-06-23 菲仕兰坎皮纳荷兰公司 营养组合物
CN114504108B (zh) * 2020-11-16 2023-06-02 内蒙古伊利实业集团股份有限公司 一种含副干酪乳杆菌与母乳低聚糖的组合物及其应用
CN114504107B (zh) * 2020-11-16 2023-08-29 内蒙古伊利实业集团股份有限公司 一种含鼠李糖乳杆菌与母乳低聚糖的组合物及其应用
WO2022100758A1 (zh) * 2020-11-16 2022-05-19 内蒙古伊利实业集团股份有限公司 一种含乳双歧杆菌与母乳低聚糖的组合物及其应用
CN114568504A (zh) * 2020-11-30 2022-06-03 内蒙古伊利实业集团股份有限公司 调控丁酸并改善肠道微环境健康的母乳低聚糖及其应用
CN112514997B (zh) * 2020-11-30 2022-03-11 内蒙古伊利实业集团股份有限公司 改善肠道微环境健康的母乳低聚糖及其应用
US20240016195A1 (en) * 2020-12-11 2024-01-18 Dsm Ip Assets B.V. Improved prebiotic formulations
AU2022258643A1 (en) * 2021-04-13 2023-09-07 Frieslandcampina Nederland B.V. Nutritional composition for stimulationg bifidobacteria
CN114223723A (zh) * 2021-12-13 2022-03-25 黑龙江飞鹤乳业有限公司 营养组合物、包含其的食品以及该营养组合物的用途
DE102021134539A1 (de) * 2021-12-23 2023-06-29 AASAYA LifeScience GmbH Synbiotikum zur Anwendung in einem Therapieverfahren
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4762822A (en) 1985-08-08 1988-08-09 Ettinger Anna C Reduction of gastrointestinal disease-producing organisms with sialic acid and gangliosides
US5260280A (en) 1989-02-07 1993-11-09 Snow Brand Milk Products Co., Ltd. Bacterial toxin neutralizer
JPH08509467A (ja) * 1993-02-26 1996-10-08 ノルマーク，ヤーン・スタツフアン 細菌接着のインヒビターとしてのオリゴ糖グリコシドの使用
WO1996002255A1 (fr) 1994-07-15 1996-02-01 Taiyo Kagaku Co., Ltd. Composition medicamenteuse contenant un derive d'acide sialique
JPH08266255A (ja) 1995-03-30 1996-10-15 Taiyo Kagaku Co Ltd 学習能力向上組成物
WO1997048388A1 (en) 1996-06-17 1997-12-24 The Board Of Trustees Of The University Of Illinois Method of retarding and ameliorating central nervous system and eye damage
JP3552856B2 (ja) 1996-09-27 2004-08-11 雪印乳業株式会社 栄養強化組成物
DE19701382A1 (de) 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
US6080787A (en) 1997-02-21 2000-06-27 Abbott Laboratories Methods for reducing the incidence of necrotizing enterocolitis
JP2001516343A (ja) 1997-02-21 2001-09-25 アボツト・ラボラトリーズ 壊死性全腸炎の発生を減少させるための方法及び組成物
SA98190002B1 (ar) 1997-03-28 2006-06-20 ذي يونيفيرسيتي اوف تننيسي ريسيرش كوربوريشن استخدام أحماض دهنية تحتوي على عدة روابط غير مشبعة polyunsaturated fatty acids لتقليل حدوث الالتهاب المعوي القولوني الناخر incidence of necrotizing enterocolitis
US5906982A (en) 1997-03-31 1999-05-25 Abbott Laboratories Nutritional formulations containing Lacto-N-neoTetraose
US6045854A (en) * 1997-03-31 2000-04-04 Abbott Laboraties Nutritional formulations containing oligosaccharides
JPH10327804A (ja) 1997-06-04 1998-12-15 Meiji Milk Prod Co Ltd 核酸関連物質、ｄｈａ、アラキドン酸及び コレステロール含有栄養組成物
US20020019991A1 (en) * 1998-04-30 2002-02-14 Abbott Laboratories Compositions containing an alpha 1,2-fucose linkage and uses thereof
US6162472A (en) * 1998-07-28 2000-12-19 University Of Virginia Patent Foundation Nutritional formula for premature infants and method of making
US6497908B1 (en) 1999-07-19 2002-12-24 Seiri Oshiro Turmeric-containing cooking oils and fats
DE19958985A1 (de) 1999-12-07 2001-06-13 Nutricia Nv Oligosaccharidmischung
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
US6630452B2 (en) 2000-02-17 2003-10-07 Wyeth Nutritional formulation containing prebiotic substances
TWI265008B (en) 2000-02-17 2006-11-01 Wyeth Corp Nutritional formulation comprising oligofructose and sialyllactose
US7090862B2 (en) 2001-03-30 2006-08-15 Abbott Laboratories Method of improving the antioxidant status of an infant
WO2003003981A2 (en) 2001-07-05 2003-01-16 Vital Basics, Inc. Compositions for improving mental performance
DE10147100A1 (de) 2001-09-25 2003-04-17 Numico Res B V Antiinfektive Kohlenhydrate
US6811801B2 (en) 2001-12-12 2004-11-02 Abbott Laboratories Methods and compositions for brightening the color of thermally processed nutritionals
DE10204000A1 (de) 2002-02-01 2003-08-14 Nutricia Nv Sialysierte Kohlenhydrate
US20040048926A1 (en) 2002-03-15 2004-03-11 Hoffman Dennis Robert Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months
AR039170A1 (es) 2002-03-28 2005-02-09 Bio Dar Ltd Co-granulos de dha y romero y metodos de uso
US20040001817A1 (en) 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
PL375071A1 (en) 2002-10-11 2005-11-14 Wyeth Nutritional formulations containing synbiotic substances
US7867541B2 (en) 2003-04-14 2011-01-11 Mead Johnson Nutrition Company Compositions and methods of formulation for enteral formulas containing sialic acid
US7951410B2 (en) 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
CN1863463B (zh) 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
CA2530170A1 (en) 2003-06-24 2005-01-06 University Of Kansas Medical Center Infant formula
MXPA06006392A (es) 2003-12-05 2007-03-15 Childrens Hosp Medical Center Composiciones de oligosacaridos y uso de estas en el tratamiento de infecciones.
US20060039954A1 (en) 2003-12-23 2006-02-23 Gierhart Dennis L Ocular formulations with neuroprotectants to reduce Alzheimer and neurotoxic risks created by large zinc dosages
US7416752B2 (en) 2004-01-06 2008-08-26 Sharp Ingrained Functional Foods, Inc. Method of fortifying seeds with an essential fatty acid, fortified seed and food product
US7851451B2 (en) 2004-03-12 2010-12-14 Mti Meta Tech Inc. Formulations for mediating inflammatory bowel disorders
US7090879B2 (en) 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
EP1721611A1 (en) 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
EP1634599A1 (en) 2004-08-20 2006-03-15 N.V. Nutricia Iimmune stimulatory infant nutrition
US20060088574A1 (en) 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
US7858578B2 (en) * 2004-12-10 2010-12-28 California Institute Of Technology Methods of inducing neuronal growth by a Fucose-α(1-2) galactose (fuc-α(1-2) gal) moiety and a lectin
US20060270739A1 (en) 2005-04-28 2006-11-30 Trustees Of Tufts College Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation
US20060247153A1 (en) 2005-04-29 2006-11-02 Mcmahon Robert J Method of improving learning and memory in mammals
US20060246146A1 (en) 2005-04-29 2006-11-02 Mcmahon Robert J Method of increasing the salivary sialic acid content in a mammal
US9179702B2 (en) 2005-07-13 2015-11-10 Abbott Laboratories Liquid nutritional compositions containing unsaturated fatty acids
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US7829126B2 (en) 2005-10-26 2010-11-09 Abbott Laboratories Infant formulas containing docosahexaenoic acid and lutein
DK1951060T3 (da) 2005-11-04 2018-01-29 Arla Foods Amba Koncentrat afledt af et mælkeprodukt beriget med naturligt forekommende sialyllactose og en fremgangsmåde til fremstilling deraf
CA2636724A1 (en) 2006-01-09 2007-08-02 Children's Hospital Medical Center Adiponectin for treatment of various disorders
EP1993565A2 (en) 2006-01-19 2008-11-26 Solazyme, Inc. Nutraceutical compositions from microalgae and related methods of production and administration
ES2553636T3 (es) 2006-03-07 2015-12-10 Nestec S.A. Mezcla simbiótica
BRPI0708701A2 (pt) 2006-03-10 2011-06-07 Nutricia Nv uso de um sacarìdeo não digerìvel solúvel em água
AU2006340316B2 (en) 2006-03-23 2013-03-28 Nestec S.A. High-calorie nutritional supplement
WO2007114683A1 (en) 2006-03-30 2007-10-11 N.V. Nutricia Milk oligosaccharides for stimulating the immune system
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
US20080003329A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Enriched infant formulas
PL2164349T3 (pl) 2006-08-04 2015-03-31 Shs Int Ltd Bezproteinowa mieszanka dla niemowląt
US20080089981A1 (en) 2006-10-17 2008-04-17 N.V. Nutricia Ketogenic diet
NL1032840C2 (nl) 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
NL1033521C2 (nl) 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
CN101668437A (zh) 2007-03-13 2010-03-10 N.V.努特里奇亚 使用含有非消化性糖的组合物改善能力的方法
NL1033698C2 (nl) 2007-04-16 2008-10-20 Friesland Brands Bv Functioneel serumeiwitproduct voor toepassing in kindervoeding en therapeutische samenstellingen, en werkwijzen ter bereiding daarvan.
US20100130537A1 (en) 2007-04-26 2010-05-27 Eisai R&D Management Co., Ltd Cinnamide compounds for dementia
US8197872B2 (en) 2007-05-17 2012-06-12 The Regents Of The University Of California Human milk oligosaccharides to promote growth of beneficial gut bacteria
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2009002145A1 (en) * 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009033011A1 (en) * 2007-09-07 2009-03-12 Children's Hospital Medical Center Use of secretor, lewis and sialyl antigen levels as predictors for disease
US10251899B2 (en) 2007-10-08 2019-04-09 Mead Johnson Nutrition Company Method for improving stool characteristics in infants
US20090118229A1 (en) 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
WO2009060073A1 (en) 2007-11-08 2009-05-14 Nestec S.A. Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates
EP2060257A1 (en) 2007-11-08 2009-05-20 Nestec S.A. Prevention and treatment of secondary infections following viral infection
WO2009067000A1 (en) 2007-11-20 2009-05-28 N.V. Nutricia Composition with synbiotics
WO2009075564A1 (en) * 2007-12-10 2009-06-18 N.V. Nutricia Paediatric fibre mixture
US8273709B2 (en) 2007-12-14 2012-09-25 Enanta Pharmaceuticals, Inc. Triazole-containing macrocyclic HCV serine protease inhibitors
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
WO2009102193A1 (en) 2008-02-12 2009-08-20 N.V. Nutricia A composition comprising bifidobacterium infantis and fructo- and galacto-oligosaccharides for the prevention of intestinal discomfort in infants
NL2001377C2 (nl) 2008-03-14 2009-09-15 Friesland Brands Bv Werkwijze voor het isoleren van siaalzuur bevattende oligosachariden, alsmede de hiermee verkrijgbare siaalzuur bevattende oligosachariden bevatttende samenstellingen.
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
EP2143341A1 (en) 2008-07-08 2010-01-13 Nestec S.A. Nutritional Composition Containing Oligosaccharide Mixture
PL2293677T3 (pl) * 2008-06-13 2018-05-30 N.V. Nutricia Kompozycja żywieniowa dla niemowląt urodzonych poprzez cięcie cesarskie
WO2010023178A1 (en) 2008-08-28 2010-03-04 Chr. Hansen A/S Pharmaceuticals comprising a bacterial polysaccharide
CA2745099C (en) 2008-12-02 2017-11-07 Prolacta Bioscience, Inc. Human milk permeate compositions and methods of making and using same
CN102257128A (zh) 2008-12-19 2011-11-23 詹内怀恩生物技术股份有限公司 岩藻糖化化合物的合成
KR20120022875A (ko) 2009-04-07 2012-03-12 글리콤 에이/에스 ２'-ｏ-푸코실락토오스의 합성
TWI381845B (zh) 2009-05-21 2013-01-11 Univ Nat Taiwan 預防和治療幽門螺旋桿菌感染的組成物
WO2011005681A1 (en) 2009-07-06 2011-01-13 Children's Hospital Medical Center Inhibiting inflammation with milk oligosaccharides
MY195771A (en) 2009-07-15 2023-02-10 Nutricia Nv Fucosyllactose as Breast Milk Identical Non-Digestible Oligosaccharide With New Functional Benefit
IN2012DN00282A (es) 2009-07-31 2015-05-08 Nestec Sa
DK2498626T3 (en) * 2009-11-12 2015-07-13 Nestec Sa FOOD COMPOSITION TO PROMOTE GAS MICROFLORAL BALANCE AND HEALTH
WO2011090926A1 (en) 2010-01-19 2011-07-28 Abbott Laboratories Nutritional formulas containing synbiotics
NL2004201C2 (en) 2010-02-05 2011-08-08 Friesland Brands Bv Use of sialyl oligosaccharides to modulate the immune system.
WO2011136636A1 (en) 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant nutrition
WO2011136647A1 (en) 2010-04-27 2011-11-03 N.V. Nutricia Use of 6'-sialyl lactose in infant and toddler nutrition
DK2593466T3 (en) 2010-07-12 2018-07-16 Univ California Oligosaccharides from cow's milk
EP2465509A1 (en) 2010-11-23 2012-06-20 Nestec S.A. Oligosaccharide composition for treating acute respiratory tract infections
CN103402376A (zh) 2010-12-31 2013-11-20 雅培制药有限公司 促进有益细菌生长的中性人乳寡糖
US20120171166A1 (en) * 2010-12-31 2012-07-05 Abbott Laboratories Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
US20200138838A1 (en) 2014-10-29 2020-05-07 Glycom A/S Composition comprising hmss/hmos and use thereof

Also Published As

Publication number Publication date
CA2822500C (en) 2022-07-26
US20220354876A1 (en) 2022-11-10
PH12013501381A1 (en) 2013-09-16
US20140249103A1 (en) 2014-09-04
WO2012092160A3 (en) 2012-10-26
MX2018005297A (es) 2021-12-08
CN108741083A (zh) 2018-11-06
CA3167205A1 (en) 2012-07-05
BR112013016929A2 (pt) 2019-09-24
HK1255687A1 (zh) 2019-08-23
WO2012092160A2 (en) 2012-07-05
MY174542A (en) 2020-04-24
EP3335576A1 (en) 2018-06-20
CA2822500A1 (en) 2012-07-05
MX2013007680A (es) 2013-09-26
NZ612455A (en) 2015-02-27
TW201233334A (en) 2012-08-16
SG191393A1 (en) 2013-08-30
US20200093847A1 (en) 2020-03-26
US11337990B2 (en) 2022-05-24
MY191538A (en) 2022-06-30
EP2658401A2 (en) 2013-11-06
SG10201707519PA (en) 2017-10-30
US20120171165A1 (en) 2012-07-05
CN103402376A (zh) 2013-11-20

Similar Documents

Publication Publication Date Title
MX2018005297A (es) Formula pediatrica sintetica para estimular celulas nerviosas entericas en el tracto gastrointestinal.
MX2013007675A (es) Combinacion simbiotica de oligosacaridos probioticos y de leche humana para promover el crecimiento de la microbiota beneficiosa.
MY169326A (en) Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
PH12017500874A1 (en) Human milk oligosaccharides for modulating inflammation
MX2021014138A (es) Metodos para usar los oligosacaridos de leche humana para mejorar la salud respiratoria de las vias aereas.
MY174541A (en) Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
MX2022011064A (es) Metodos para disminuir la incidencia de la enterocolitis necrotizante en bebes, infantes, o ni?os al usar los oligosacaridos de leche humana.
MY186188A (en) Nutritional phytonutrient compositions
MY173726A (en) Synbiotics combination for brain improvement
MY189329A (en) Mixture of non-digestible oligosaccharides for stimulating the immune system
MX2014000895A (es) Galacto-oligosacaridos para prevenir lesion y/o promover cicatrizacion del tracto gastrointestinal.
MX352040B (es) Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas.
MX2011007872A (es) Composicion nutrimental para niños que presentan reflujo, colico y/o estreñimiento.
MY175195A (en) Nutritional compositions
IN2014DN09248A (es)
IN2015DN01696A (es)
PH12017500873A1 (en) Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
TH121222B (th) ของผสมของโอลิโกแซ็กคาไรด์ชนิดไม่สามารถย่อยได้สำหรับการกระตุ้นระบบภูมิคุ้มกัน
UA33597U (ru) Способ профилактики и коррекции дисбиотических состояний у новорожденных, рожденных от матерей с герпесвирусной инфекцией
UA90908U (uk) Спосіб лікування вторинної лактазної недостатності у дітей раннього віку

Legal Events

Date Code Title Description
FG Grant or registration